Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13006
Revised: February 11, 2014
Accepted: April 5, 2014
Published online: September 28, 2014
Processing time: 310 Days and 16 Hours
Colon capsule endoscopy is recommended in Europe alternatively to colonoscopy for colorectal cancer screening in average risk individuals. The procedure has also been proposed to complete colon examination in cases of incomplete colonoscopy or when colonoscopy is contraindicated or refused by the patient. As tissue samples cannot be obtained with the current capsule device, colon capsule endoscopy has no place in diagnosing ulcerative colitis or in dysplasia surveillance. Nevertheless, data are accumulating regarding its feasibility to examine ulcerative colitis disease extent and to monitor disease activity and mucosal healing, even though reported results on the capsule’s performance in this field vary greatly. In this review we present the currently available evidence for the use of colon capsule endoscopy to complement colonoscopy failure to reach the cecum and its use to evaluate ulcerative colitis disease activity and extent. Moreover, we provide an outlook on issues requiring further investigation before the capsule becomes a mainstream alternative to colonoscopy in such cases.
Core tip: Colon capsule endoscopy has a potential to become an endoscopic modality to investigate the colon after incomplete colonoscopy and to estimate ulcerative colitis extent and activity. While for the former indication strong evidence has been accumulating, for the latter the evidence is still limited.